Is the RSV Shot Worth the Risk to Your Baby?
STORY AT-A-GLANCE Nirsevimab, a new RSV shot for infants, has raised safety concerns after reports of infant deaths following administration. The reporting system for adverse events is unclear, potentially leading to underreporting Unlike conventional vaccines, nirsevimab is a monoclonal antibody. Its widespread use in children is unprecedented, and long-term safety data is limited Clinical trials […]
Discuss on Nostr!
Nostr Note ID note1jflkdv5dcfaqvzkk54kk3e8scr2jd2wqvaptuzkl6ua67xkaj6zs9x8vga Open on Primal.net Open on Snort.social Open on Iris.to Open on Coracle.social
New to Nostr?
Create an account now & join the conversation!
Promote it on DissentWatch!
- To advertise this post for $0.02 per visit send bitcoins to the address below
- The post will be promoted daily via social media & our "Featured News" display in multiple places
- You can add more anytime
- Ranking order in the Featured News box is based on the balance remaining
Received: 0 mBTC (0.00 USD)
Spent: 0 mBTC (0.00 USD)
Balance: 0 mBTC (0.00 USD)
The amounts above may be lagging behind. If you just sent a payment click below to get more up to date results and push the post to the "Featured News" box faster.